These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 22978669)
1. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing meal. Hosaka H; Kusano M; Zai H; Kawada A; Kuribayashi S; Shimoyama Y; Nagoshi A; Maeda M; Kawamura O; Mori M Aliment Pharmacol Ther; 2012 Nov; 36(9):895-903. PubMed ID: 22978669 [TBL] [Abstract][Full Text] [Related]
2. Monosodium glutamate raises antral distension and plasma amino acid after a standard meal in humans. Boutry C; Matsumoto H; Airinei G; Benamouzig R; Tomé D; Blachier F; Bos C Am J Physiol Gastrointest Liver Physiol; 2011 Jan; 300(1):G137-45. PubMed ID: 21030612 [TBL] [Abstract][Full Text] [Related]
3. The addition of monosodium glutamate and inosine monophosphate-5 to high-protein meals: effects on satiety, and energy and macronutrient intakes. Luscombe-Marsh ND; Smeets AJ; Westerterp-Plantenga MS Br J Nutr; 2009 Sep; 102(6):929-37. PubMed ID: 19267954 [TBL] [Abstract][Full Text] [Related]
5. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662 [TBL] [Abstract][Full Text] [Related]
6. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia. Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679 [TBL] [Abstract][Full Text] [Related]
7. The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled study. Stevens JE; Horowitz M; Deacon CF; Nauck M; Rayner CK; Jones KL Aliment Pharmacol Ther; 2012 Aug; 36(4):379-90. PubMed ID: 22738299 [TBL] [Abstract][Full Text] [Related]
8. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675 [TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses. Little TJ; Pilichiewicz AN; Russo A; Phillips L; Jones KL; Nauck MA; Wishart J; Horowitz M; Feinle-Bisset C J Clin Endocrinol Metab; 2006 May; 91(5):1916-23. PubMed ID: 16492694 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920 [TBL] [Abstract][Full Text] [Related]
11. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation. Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144 [TBL] [Abstract][Full Text] [Related]
12. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1. Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531 [TBL] [Abstract][Full Text] [Related]
13. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects. Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119 [TBL] [Abstract][Full Text] [Related]
15. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial. Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes. Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852 [TBL] [Abstract][Full Text] [Related]
17. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. Flint A; Kapitza C; Hindsberger C; Zdravkovic M Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616 [TBL] [Abstract][Full Text] [Related]
18. Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Meier JJ; Goetze O; Anstipp J; Hagemann D; Holst JJ; Schmidt WE; Gallwitz B; Nauck MA Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E621-5. PubMed ID: 14678954 [TBL] [Abstract][Full Text] [Related]